The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled…

Overview of attention for article published in The Journal of Headache and Pain, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 31 X posts from 26 X users, with an upper bound of 23,989 followers.

RT @SaitAshina: Lu AG09222, an investigational humanized monoclonal antibody directed against #PACAP ligand, may be a potential therapy aga…

RT @MessoudAshina: The effect of anti PACAP monoclonal antibody on PACAP38- induced physiological responses in humans. Potential for migrai…

RT @hmru_cph: Promising results 👉 Lu AG09222 inhibited PACAP38-induced cephalic vasodilation and reduced concomitant headache 🧐🌟 Exciting p…

AG09222 The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache i https://t.co/y1TugDGSdF https://t.co/bYG58QwBqM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 27 additional X posts.